structure of InhA from Mycobacterium tuberculosis in complex with 4-(4-((4-butyl-1H-1,2,3-triazol-1-yl)methyl)-2-hydroxyphenoxy)benzaldehyde (compound 5e)

structure of InhA from Mycobacterium tuberculosis in complex with 4-(4-((4-butyl-1H-1,2,3-triazol-1-yl)methyl)-2-hydroxyphenoxy)benzaldehyde (compound 5e) Descriptor: 4-[4-[(4-butyl-1,2,3-triazol-1-yl)methyl]-2-oxidanyl-phenoxy]benzaldehyde, Enoyl-[acyl-carrier-protein] reductase [NADH], NICOTINAMIDE-ADENINE-DINUCLEOTIDE, ... Authors: Tamhaev, R, Valentin, L, Lherbet, C, Azema-Despeyroux, J, Mourey, L, Maveyraud, L. Deposit date: 2026-02-05 Release date: 2026-07-15 Last modified: 2026-08-05 Method: X-RAY DIFFRACTION (2.102 Å) Cite: Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis . J.Med.Chem., 69, 2026